Is metformin use associated with cognitive, physical and cardiovascular outcomes in older adults with type 2 diabetes? A secondary analysis of the SCOPE multicentre prospective cohort study.

Wallensten J, Ärnlöv J, Muglia L, Soraci L, Lattanzio F, Fabbietti P, Artzi-Medvedik R, Melzer I, Formiga F, Moreno-Gónzalez R, Kostka T, Guligowska A, Chrzastek Z, Piglowska M, Roller-Wirnsberger R, Wirnsberger G, Tap L, Mattace-Raso F, Carlsson AC

Open source

DOI: 10.1136/bmjopen-2025-114393
Published: 2026 Nov 9
Container: BMJ open
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2025-114393,
  title = {Is metformin use associated with cognitive, physical and cardiovascular outcomes in older adults with type 2 diabetes? A secondary analysis of the SCOPE multicentre prospective cohort study.},
  author = {Wallensten J and Ärnlöv J and Muglia L and Soraci L and Lattanzio F and Fabbietti P and Artzi-Medvedik R and Melzer I and Formiga F and Moreno-Gónzalez R and Kostka T and Guligowska A and Chrzastek Z and Piglowska M and Roller-Wirnsberger R and Wirnsberger G and Tap L and Mattace-Raso F and Carlsson AC},
  year = {2026},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2025-114393},
  url = {https://doi.org/10.1136/bmjopen-2025-114393}
}

RIS

TY  - JOUR
TI  - Is metformin use associated with cognitive, physical and cardiovascular outcomes in older adults with type 2 diabetes? A secondary analysis of the SCOPE multicentre prospective cohort study.
AU  - Wallensten J
AU  - Ärnlöv J
AU  - Muglia L
AU  - Soraci L
AU  - Lattanzio F
AU  - Fabbietti P
AU  - Artzi-Medvedik R
AU  - Melzer I
AU  - Formiga F
AU  - Moreno-Gónzalez R
AU  - Kostka T
AU  - Guligowska A
AU  - Chrzastek Z
AU  - Piglowska M
AU  - Roller-Wirnsberger R
AU  - Wirnsberger G
AU  - Tap L
AU  - Mattace-Raso F
AU  - Carlsson AC
PY  - 2026
JO  - BMJ open
DO  - 10.1136/bmjopen-2025-114393
UR  - https://doi.org/10.1136/bmjopen-2025-114393
ER  -

APA

J, W., J, Ä., L, M., L, S., F, L., P, F., R, A., I, M., F, F., R, M., T, K., A, G., Z, C., M, P., R, R., G, W., L, T., F, M., & AC, C. (2026). Is metformin use associated with cognitive, physical and cardiovascular outcomes in older adults with type 2 diabetes? A secondary analysis of the SCOPE multicentre prospective cohort study.. BMJ open. https://doi.org/10.1136/bmjopen-2025-114393

Source records

pubmed · retrieved 2026-11-10T12:36:19.331Z